Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Korean Real-world Montelukast Use in Mild Asthmatic Children with Allergic Rhinitis
2014-004748-37Phase 4
- Sponsor
- MSD
- Start
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of montelukast in asthma and allergic rhinitis (AR), sponsored by MSD. Primary endpoint: Daytime Asthma Symptom Score at 12 weeks.
02
Drugs
montelukast
03
Conditions
asthmaallergic rhinitis (AR)
Beyond the preview
Go deeper on 2014-004748-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004748-37.